Back to catalogue

Share this wine

1982 COMPAGNIE MEDOCAINE DES GRANDS CRUS Château Gruaud-Larose Saint-Julien Grand cru classé

COMPAGNIE MEDOCAINE DES GRANDS CRUS Château Gruaud-Larose Saint-Julien Grand cru classé 1982

895.00 CAD

$895.00

  • Portfolio
  • Portfolio
  • Réserve & sélection
  • Product code
  • Product code
  • 11239279
  • Format
  • Format
  • 6x750ml
  • Listing type
  • Listing type
  • SAQ Signature
  • Status
  • Status
  • Store Only
  • Country
  • Country
  • France
  • Regulated designation
  • Regulated designation
  • Appellation origine controlée (AOC)
  • Region
  • Region
  • Bordeaux
  • Appellation
  • Appellation
  • Saint-Julien
  • Classification
  • Classification
  • Grand cru classé
  • Varietal(s)
  • Varietal(s)
  • Cabernet Sauvignon
    Merlot
    Cabernet Franc
    Petit Verdot
  • Color
  • Color
  • Red
  • Sugar
  • Sugar
  • Dry
  • Closure type
  • Closure type
  • Cork
  • About this winery

    OUR STORY Within 40 years, Compagnie Médocaine des Grands Crus has established itself as one of the most respected merchants in the Bordeaux wine trade, both within France and abroad. OUR CUSTOMERS Compagnie Médocaine des Grands Crus sells mainly to traditional channels (restaurants, hotels, wine shops) and also to wholesalers and quality supermarkets. OUR EXPERTISE We limit our activity to quality wines. These wines are carefully and severely selected. The Passion of all our partners :...

    See the COMPAGNIE MEDOCAINE DES GRANDS CRUS detail page for more information on this brand

Press reviews

  • - 98 Points -

    Robert Parker, June 2009

    A massive wine that is clearly of first-growth quality in this vintage, the 1982 Gruaud Larose remains a youngster. A broodingly dense, thick, unctuously textured, inky/plum/garnet/purple color offers up scents of beef blood, steak tartare, cassis, herbs, tobacco, and underbrush. One of the most concentrated wines of the vintage (...), it is a huge, full-bodied, weighty, rich wine whose tannins are getting silkier and silkier. It appears set for another 30-40 years of life. (...)

    See detailed press review